| Literature DB >> 22178229 |
Xuri Li1, Anil Kumar, Fan Zhang, Chunsik Lee, Zhongshu Tang.
Abstract
No other member of the VEGF (vascular endothelial growth factor) family has been as mysterious as VEGF-B. Notwithstanding its name, VEGF-B can hardly be regarded as a growth factor because growth occurs fairly normally in Vegf-b deficient mice. Moreover, VEGF-B is barely angiogenic under most conditions, although it was expected to be an angiogenic factor for a long time. Under certain conditions, VEGF-B has been shown to be involved in blood vessel growth. Under other conditions, however, VEGF-B can act to inhibit tumor growth and angiogenesis. Given these contradictory findings, the biological function of VEGF-B appears enigmatic. In this review, we summarize recent advances in VEGF-B biology and discuss its multifaceted roles, the underlying mechanisms, and the potential therapeutic implications. Published by Elsevier Ltd.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22178229 DOI: 10.1016/j.molmed.2011.11.006
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951